VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

735 hedge funds and large institutions have $45.2B invested in Vertex Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 292 increasing their positions, 226 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
735
Holders Change
+31
Holders Change %
+4.4%
% of All Funds
15.93%
Holding in Top 10
13
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-18.75%
% of All Funds
0.28%
New
96
Increased
292
Reduced
226
Closed
59
Calls
$303M
Puts
$244M
Net Calls
+$59.3M
Net Calls Change
+$68.5M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$727M
2
Capital World Investors
Capital World Investors
California
+$190M
3
HL
Harding Loevner
New Jersey
+$138M
4
Renaissance Technologies
Renaissance Technologies
New York
+$137M
5
State Street
State Street
Massachusetts
+$118M

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$365M
2
Capital Research Global Investors
Capital Research Global Investors
California
-$150M
3
Citadel Advisors
Citadel Advisors
Florida
-$137M
4
FAM
Fred Alger Management
New York
-$114M
5
Millennium Management
Millennium Management
New York
-$114M
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
$257M +$79.6M +432,709 +45%
FAM
27
Fred Alger Management
New York
$252M -$114M -621,959 -31%
UBS AM
28
UBS AM
Illinois
$250M -$467K -2,539 -0.2%
BB
29
BB Biotech
Switzerland
$239M -$13M -70,445 -5%
Capital Research Global Investors
30
Capital Research Global Investors
California
$230M -$150M -815,018 -39%
PI
31
Putnam Investments
Massachusetts
$221M -$48.3M -262,303 -18%
Franklin Resources
32
Franklin Resources
California
$213M -$9.82M -53,371 -4%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$203M -$2.38M -12,949 -1%
Sumitomo Mitsui Trust Group
34
Sumitomo Mitsui Trust Group
Japan
$203M +$5.65M +30,705 +3%
Bank of America
35
Bank of America
North Carolina
$199M -$100M -543,826 -33%
Charles Schwab
36
Charles Schwab
California
$195M +$14.5M +78,875 +8%
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$194M +$10.7M +58,181 +6%
TCIM
38
TIAA CREF Investment Management
New York
$185M +$2.28M +12,369 +1%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$185M +$47.5M +258,400 +35%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$185M -$30.4M -165,372 -14%
O
41
OrbiMed
New York
$176M -$32.7M -177,900 -16%
American Century Companies
42
American Century Companies
Missouri
$167M -$9.1M -49,448 -5%
JIM
43
Jupiter Investment Management
United Kingdom
$167M +$30.6M +166,393 +22%
EVM
44
Eaton Vance Management
Massachusetts
$166M -$1.01M -5,497 -0.6%
PAM
45
Panagora Asset Management
Massachusetts
$158M -$88.2M -479,597 -36%
Swiss National Bank
46
Swiss National Bank
Switzerland
$157M +$4.05M +22,000 +3%
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
$155M +$9.08M +49,336 +6%
MWNA
48
Marshall Wace North America
New York
$146M +$53.7M +291,952 +58%
PPA
49
Parametric Portfolio Associates
Washington
$145M +$18.7M +101,608 +15%
Janus Henderson Group
50
Janus Henderson Group
United Kingdom
$141M -$21M -114,085 -13%
1
2
3 4 5